Rocket


News + Filings
Transactions



Thorp Clay

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
05/19/2023PhaseBio Pharmaceuticals IncPHASExerciseRestricted Stock Units3.8k$0.00$0 05/19/2023
12/21/2022Clearside Biomedical, Inc.CLSDPurchaseCommon Stock14k$1.02$14.3k 12/21/2022
12/15/2022Clearside Biomedical, Inc.CLSDOther (disposition)Common Stock1.4M$0.00$0See footnote12/15/2022
12/15/2022Clearside Biomedical, Inc.CLSDOther (acquisition)Common Stock8.5k$0.00$0 12/15/2022
06/22/2022Clearside Biomedical, Inc.CLSDGrantStock Option (right to buy)30k$1.62$48.6k 06/22/2022
05/19/2022PhaseBio Pharmaceuticals IncPHASGrantNon-employee Director Stock Option (right to buy)17.5k$0.84$14.7k 05/19/2022
05/19/2022PhaseBio Pharmaceuticals IncPHASGrantRestricted Stock Units3.8k$0.00$0 05/19/2022
05/17/2022Vigil Neuroscience, Inc. PurchaseCommon Stock14.9k$2.97$44.2kBy Hatteras Venture Partners VI, L.P.05/16/2022
05/16/2022Vigil Neuroscience, Inc. PurchaseCommon Stock21.8k$2.76$60.2kBy Hatteras Venture Partners VI, L.P.05/16/2022
03/28/2022Vigil Neuroscience, Inc. PurchaseCommon Stock3k$7.20$21.6k 03/28/2022
01/11/2022Vigil Neuroscience, Inc. ConversionCommon Stock1.3M$0.00$0By Hatteras Venture Partners VI, L.P.01/11/2022
01/11/2022Vigil Neuroscience, Inc. PurchaseCommon Stock265k$14.00$3.7MBy Hatteras Venture Partners VI, L.P.01/11/2022
01/11/2022Vigil Neuroscience, Inc. ConversionSeries A Preferred Stock2.6M$0.00$0By Hatteras Venture Partners VI, L.P.01/11/2022
01/11/2022Vigil Neuroscience, Inc. ConversionSeries B Preferred Stock926.5k$0.00$0By Hatteras Venture Partners VI, L.P.01/11/2022
06/10/2021Clearside Biomedical, Inc.CLSDGrantStock Option (right to buy)25k$3.11$77.8k 06/10/2021
06/03/2021PhaseBio Pharmaceuticals IncPHASGrantNon-employee Director Stock Option (right to buy)14k$3.53$49.4k 06/03/2021
02/10/2021Clearside Biomedical, Inc.CLSDSaleCommon Stock32.9k$4.43$145.6k 02/10/2021
02/10/2021Clearside Biomedical, Inc.CLSDSaleCommon Stock32.9k$4.43$145.6kSee Footnotes02/10/2021
11/24/2020PhaseBio Pharmaceuticals IncPHASPurchaseCommon Stock2k$3.50$7k 11/23/2020
11/23/2020PhaseBio Pharmaceuticals IncPHASPurchaseCommon Stock3k$3.67$11k 11/23/2020
11/16/2020PhaseBio Pharmaceuticals IncPHASOther (disposition)Common Stock52.4k$0.00$0By Hatteras Venture Partners I, LP11/16/2020
11/16/2020PhaseBio Pharmaceuticals IncPHASOther (acquisition)Common Stock2.1k$0.00$0 11/16/2020
11/16/2020PhaseBio Pharmaceuticals IncPHASOther (acquisition)Common Stock10.6k$0.00$0By Catalysta Ventures, LLC11/16/2020
06/18/2020Clearside Biomedical, Inc.CLSDGrantStock Option (right to buy)25k$2.00$50k 06/18/2020
06/03/2020PhaseBio Pharmaceuticals IncPHASGrantNon-employee Director Stock Option (right to buy)16k$4.86$77.8k 06/03/2020
11/22/2019Clearside Biomedical, Inc.CLSDGrantCommon Stock1.5M$1.05$1.6MSee Footnote11/22/2019
07/01/2019PhaseBio Pharmaceuticals IncPHASSaleCommon Stock2k$14.00$28.2kBy Hatteras Venture Partners III, LP07/01/2019
07/01/2019PhaseBio Pharmaceuticals IncPHASSaleCommon Stock180$14.00$2.5kBy Hatteras Venture Affiliates III, LP07/01/2019
07/01/2019PhaseBio Pharmaceuticals IncPHASSaleCommon Stock255$14.00$3.6kBy Hatteras Venture Partners I, LP07/01/2019
07/01/2019PhaseBio Pharmaceuticals IncPHASSaleCommon Stock459$14.00$6.4kBy Venture Capital Multiplier Fund07/01/2019
06/20/2019Clearside Biomedical, Inc.CLSDGrantStock Option (right to buy)20k$1.07$21.4k 06/20/2019
06/18/2019PhaseBio Pharmaceuticals IncPHASSaleCommon Stock277$14.00$3.9kBy Hatteras Venture Partners III, LP06/18/2019
06/18/2019PhaseBio Pharmaceuticals IncPHASSaleCommon Stock25$14.00$350By Hatteras Venture Affiliates III, LP06/18/2019
06/18/2019PhaseBio Pharmaceuticals IncPHASSaleCommon Stock35$14.00$490By Hatteras Venture Partners I, LP06/18/2019
06/18/2019PhaseBio Pharmaceuticals IncPHASSaleCommon Stock63$14.00$882By Venture Capital Multiplier Fund06/18/2019
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy